Cargando…
Rituximab Treatment for Membranous Nephropathy: A French Clinical and Serological Retrospective Study of 28 Patients
The development of well-tolerated and effective therapies that target the pathogenesis of membranous nephropathy (MN) would be useful. Our objective was to evaluate the efficacy of rituximab in MN. We analyzed the outcome of 28 patients treated with rituximab for idiopathic MN. Anti-PLA(2)R antibodi...
Autores principales: | Michel, Pierre-Antoine, Dahan, Karine, Ancel, Pierre-Yves, Plaisier, Emmanuelle, Mojaat, Rachid, De Seigneux, Sophie, Daugas, Eric, Matignon, Marie, Mesnard, Laurent, Karras, Alexandre, François, Hélène, Pardon, Agathe, Caudwell, Valérie, Debiec, Hanna, Ronco, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290855/ https://www.ncbi.nlm.nih.gov/pubmed/22470399 http://dx.doi.org/10.1159/000333068 |
Ejemplares similares
-
Efficacy of Rituximab in a Patient With Partial Clinical Remission and Persistent Circulating PLA2R-Ab
por: Georges, Elodie, et al.
Publicado: (2019) -
Rituximab in Patients With Phospholipase A2 Receptor–Associated Membranous Nephropathy and Severe CKD
por: Hanset, Nicolas, et al.
Publicado: (2019) -
Rituximab alone as induction therapy for membranous lupus nephritis: A multicenter retrospective study
por: Chavarot, Nathalie, et al.
Publicado: (2017) -
Advances in Membranous Nephropathy
por: Ronco, Pierre, et al.
Publicado: (2021) -
Efficacy and Safety of Rituximab in Hepatitis B Virus–Associated PLA2R-Positive Membranous Nephropathy
por: Berchtold, Lena, et al.
Publicado: (2017)